IBM Watson Health: How cognitive technologies have begun transforming clinica...Maged N. Kamel Boulos
Cite as: Kamel Boulos MN. IBM Watson Health: how cognitive technologies have begun transforming clinical medicine and healthcare (Oral session IV – Patient safety tools, Thursday 19 May 2016, 15:45-16:45, Hotel Puijonsarvi, Kuopio). In: Proceedings of the 4th Nordic Conference on Research in Patient Safety and Quality in Healthcare (NSQH2016), Kuopio, Finland, 18-20 May 2016 (organised by University of Eastern Finland), p.29. URL: http://www.uef.fi/NSQH2016 (In: Nykanen I (ed.). The 4th Nordic Conference on Research in Patient Safety and Quality in Healthcare. Kuopio, Finland, May 18-20, 2016. Program and Abstracts. Publications of the University of Eastern Finland. Report and Studies in Health Sciences 21. 2016, p.29 (of 119 p.). ISBN: 978-952-61-2130-7 (nid.), ISSNL: 1798-5722, ISSN: 1798-5730.)
IBM Watson health: how cognitive technologies have begun transforming clinical medicine and healthcare
Maged N Kamel Boulos
ABSTRACT
Background: IBM Watson Health (http://www.ibm.com/smarterplanet/us/en/ibmwatson/health/) belongs to a new generation of smart cognitive computing technologies (a type of artificial intelligence) that are poised to transform the way healthcare is delivered, and to vastly improve clinical outcomes, quality of care and patient safety.
Objectives: Our goal was to collect and document the huge potential of a range of emerging and exemplary uses of IBM Watson in healthcare in both developed and developing country settings.
Methods: A survey of current peer reviewed and grey literature has been conducted, looking for reports and case studies involving the use of IBM Watson in different health and healthcare applications.
Results, conclusions and clinical implications: With its ability to make sense of unstructured medical information by analysing the meaning and context of natural language, and uncovering important knowledge buried within large volumes of data and information, including medical images, IBM Watson is exceptionally well suited for clinical and healthcare decision support, where there are often elements of ambiguity and uncertainty. It has been (or is currently being) successfully deployed in many developed countries in the West, as well as in developing countries, such as India and South Africa. IBM Watson unlocks a complex case by acquiring information from multiple sources, e.g., accessing the electronic patient record, then parsing all related medical evidence at up to 60 million pages per second. After processing all of this information, Watson offers relevant and prioritised suggestions to the decision-maker, e.g., helping clinicians identify the best diagnosis and treatment options in complex oncology cases, and providing hospital managers with new operational insights. The ultimate goals are to reduce cost, medical errors, mortality rates, and help improve patients' quality of life.
Data Visualization 101: How to Design Charts and GraphsVisage
Learn to design effective charts and graphs.
Your data is only as good as your ability to understand and communicate it. The right visualization is essential to incite a desired action, whether from customers or colleagues. But most marketers aren’t mathematicians or adept at data visualization. Fortunately, you don’t need a PhD in statistics to crack the data visualization code.
This talk gives an introduction about Healthcare Use cases - The AI ladder and Lifestyle AI at Scale Themes The iterative nature of the workflow and some of the important components to be aware in developing AI health care solutions were being discussed. The different types of algorithms and when machine learning might be more appropriate in deep learning or the other way will also be discussed. Use cases in terms of examples are also shared as part of this presentation .
Within the overall healthcare industry, home healthcare represents a small, but exciting opportunity that will grow immensely in the years ahead. The key drivers for the home healthcare industry include the increasing prevalence of chronic diseases, favorable demographics, increasing disposable incomes, and quest for better preventive care.
The global home healthcare market is expected to reach USD 368B by 2020 at a CAGR of 8.0% during the forecast period.
The home healthcare market in India is fragmented and comprises of some exciting start-ups; hospitals that have entered the segment; hospitals that have aligned with home healthcare providers; large MNCs and VC-backed firms.
The Indian home healthcare market is expected to reach USD 6.2B by 2020 at a CAGR of 18.0% during the forecast period.
Indian home healthcare companies are focused on elderly care; rehabilitation; diabetes management. There is a clear focus on innovation, and companies are looking to bank on wearable medical devices that can record patient data in real time and can trigger alerts in the system for quick and pre-emptive action.
The CMR IMG report will help readers to get the big picture on the Indian Home Healthcare Sector. Readers will be able to understand current demand and supply drivers in the home healthcare market, and the major market drivers, restraints, opportunities, and challenges facing this sector.
The report segments the home healthcare market based on devices and services.
Key market players include Portea Medical; Unique Home Healthcare; India Home Healthcare; Nightingales; Homital; Pramaticare; Max Home Healthcare.
Economic Development in Information and AI Era: Experiences and ExpectationsChinnasamy Muthuraja
Thank God 🙏...
My Participation and Presentation on 'Economic Development in Information and AI Era: Experiences and Expectations' in
Refresher Course (ONLINE MODE) in Economics on the theme of "Economics and Social Development in Information and A-I Era" from 13-26 September 2023 during 2-5pm on 15.09.2023 organised by Madurai Kamaraj University, Madurai...
Thank Dr. Nagarathinam Swaminathan , Member - Syndicate, Chairperson i/c, School of Economics, Co-ordinator, Refresher Course in Economics and Social Development in Information and A-I Era, UGC - HRDC, Madurai Kamaraj University and Dr. Sadasivam Koppukandan , Dy- Dy-Coordinator, Refresher Course in Economics, School of Economics, Madurai Kamaraj University...
IBM Watson Health: How cognitive technologies have begun transforming clinica...Maged N. Kamel Boulos
Cite as: Kamel Boulos MN. IBM Watson Health: how cognitive technologies have begun transforming clinical medicine and healthcare (Oral session IV – Patient safety tools, Thursday 19 May 2016, 15:45-16:45, Hotel Puijonsarvi, Kuopio). In: Proceedings of the 4th Nordic Conference on Research in Patient Safety and Quality in Healthcare (NSQH2016), Kuopio, Finland, 18-20 May 2016 (organised by University of Eastern Finland), p.29. URL: http://www.uef.fi/NSQH2016 (In: Nykanen I (ed.). The 4th Nordic Conference on Research in Patient Safety and Quality in Healthcare. Kuopio, Finland, May 18-20, 2016. Program and Abstracts. Publications of the University of Eastern Finland. Report and Studies in Health Sciences 21. 2016, p.29 (of 119 p.). ISBN: 978-952-61-2130-7 (nid.), ISSNL: 1798-5722, ISSN: 1798-5730.)
IBM Watson health: how cognitive technologies have begun transforming clinical medicine and healthcare
Maged N Kamel Boulos
ABSTRACT
Background: IBM Watson Health (http://www.ibm.com/smarterplanet/us/en/ibmwatson/health/) belongs to a new generation of smart cognitive computing technologies (a type of artificial intelligence) that are poised to transform the way healthcare is delivered, and to vastly improve clinical outcomes, quality of care and patient safety.
Objectives: Our goal was to collect and document the huge potential of a range of emerging and exemplary uses of IBM Watson in healthcare in both developed and developing country settings.
Methods: A survey of current peer reviewed and grey literature has been conducted, looking for reports and case studies involving the use of IBM Watson in different health and healthcare applications.
Results, conclusions and clinical implications: With its ability to make sense of unstructured medical information by analysing the meaning and context of natural language, and uncovering important knowledge buried within large volumes of data and information, including medical images, IBM Watson is exceptionally well suited for clinical and healthcare decision support, where there are often elements of ambiguity and uncertainty. It has been (or is currently being) successfully deployed in many developed countries in the West, as well as in developing countries, such as India and South Africa. IBM Watson unlocks a complex case by acquiring information from multiple sources, e.g., accessing the electronic patient record, then parsing all related medical evidence at up to 60 million pages per second. After processing all of this information, Watson offers relevant and prioritised suggestions to the decision-maker, e.g., helping clinicians identify the best diagnosis and treatment options in complex oncology cases, and providing hospital managers with new operational insights. The ultimate goals are to reduce cost, medical errors, mortality rates, and help improve patients' quality of life.
Data Visualization 101: How to Design Charts and GraphsVisage
Learn to design effective charts and graphs.
Your data is only as good as your ability to understand and communicate it. The right visualization is essential to incite a desired action, whether from customers or colleagues. But most marketers aren’t mathematicians or adept at data visualization. Fortunately, you don’t need a PhD in statistics to crack the data visualization code.
This talk gives an introduction about Healthcare Use cases - The AI ladder and Lifestyle AI at Scale Themes The iterative nature of the workflow and some of the important components to be aware in developing AI health care solutions were being discussed. The different types of algorithms and when machine learning might be more appropriate in deep learning or the other way will also be discussed. Use cases in terms of examples are also shared as part of this presentation .
Within the overall healthcare industry, home healthcare represents a small, but exciting opportunity that will grow immensely in the years ahead. The key drivers for the home healthcare industry include the increasing prevalence of chronic diseases, favorable demographics, increasing disposable incomes, and quest for better preventive care.
The global home healthcare market is expected to reach USD 368B by 2020 at a CAGR of 8.0% during the forecast period.
The home healthcare market in India is fragmented and comprises of some exciting start-ups; hospitals that have entered the segment; hospitals that have aligned with home healthcare providers; large MNCs and VC-backed firms.
The Indian home healthcare market is expected to reach USD 6.2B by 2020 at a CAGR of 18.0% during the forecast period.
Indian home healthcare companies are focused on elderly care; rehabilitation; diabetes management. There is a clear focus on innovation, and companies are looking to bank on wearable medical devices that can record patient data in real time and can trigger alerts in the system for quick and pre-emptive action.
The CMR IMG report will help readers to get the big picture on the Indian Home Healthcare Sector. Readers will be able to understand current demand and supply drivers in the home healthcare market, and the major market drivers, restraints, opportunities, and challenges facing this sector.
The report segments the home healthcare market based on devices and services.
Key market players include Portea Medical; Unique Home Healthcare; India Home Healthcare; Nightingales; Homital; Pramaticare; Max Home Healthcare.
Economic Development in Information and AI Era: Experiences and ExpectationsChinnasamy Muthuraja
Thank God 🙏...
My Participation and Presentation on 'Economic Development in Information and AI Era: Experiences and Expectations' in
Refresher Course (ONLINE MODE) in Economics on the theme of "Economics and Social Development in Information and A-I Era" from 13-26 September 2023 during 2-5pm on 15.09.2023 organised by Madurai Kamaraj University, Madurai...
Thank Dr. Nagarathinam Swaminathan , Member - Syndicate, Chairperson i/c, School of Economics, Co-ordinator, Refresher Course in Economics and Social Development in Information and A-I Era, UGC - HRDC, Madurai Kamaraj University and Dr. Sadasivam Koppukandan , Dy- Dy-Coordinator, Refresher Course in Economics, School of Economics, Madurai Kamaraj University...
Artificial Intelligence in the Hospital SettingDaniel Faggella
This presentation was given at the AI Applications Summit (an event for healthcare and pharma professionals) in December 2017. The presentation itself covers to current traction of artificial intelligence in the hospital setting, as well as the unique challenges of applying AI in healthcare (including compliance, resistance from some doctors, the "black box" problem of machine learning, and more). Includes references to Machine Learning in Healthcare Executive Consensus: https://www.techemergence.com/machine-learning-in-healthcare-executive-consensus/
Artificial intelligence (AI) is already transforming healthcare. It's an invaluable tool, capable of storing and processing vast amounts of data almost simultaneously. AI allows for rapid and accurate diagnosis, early detection, advanced research and much more.
IBM Watson overview presented by Mike Pointer, Watson Sr. Solution Architect, at Penn State's Nittany Watson Challenge Immersion event on January 19-20, 2017.
Outlines Watson accomplishments in 2012 and new products announced in early 2013. THIS DOCUMENT IS PROVIDED FOR REFERENCE PURPOSES ONLY. IBM RESERVES THE RIGHTS TO MAKE CHANGES TO THIS EVOLVING PORTFOLIO.
Discover what comes next for IBM Watson and the industries particularly suited for Watson solutions, such as healthcare, banking, and the financial sector. All of which deal with massive amounts of unstructured data coming from various sources. Find out how the advanced analytics used in Watson are being put to work in businesses around the world.
Artificial Intelligence in the Hospital SettingDaniel Faggella
This presentation was given at the AI Applications Summit (an event for healthcare and pharma professionals) in December 2017. The presentation itself covers to current traction of artificial intelligence in the hospital setting, as well as the unique challenges of applying AI in healthcare (including compliance, resistance from some doctors, the "black box" problem of machine learning, and more). Includes references to Machine Learning in Healthcare Executive Consensus: https://www.techemergence.com/machine-learning-in-healthcare-executive-consensus/
Artificial intelligence (AI) is already transforming healthcare. It's an invaluable tool, capable of storing and processing vast amounts of data almost simultaneously. AI allows for rapid and accurate diagnosis, early detection, advanced research and much more.
IBM Watson overview presented by Mike Pointer, Watson Sr. Solution Architect, at Penn State's Nittany Watson Challenge Immersion event on January 19-20, 2017.
Outlines Watson accomplishments in 2012 and new products announced in early 2013. THIS DOCUMENT IS PROVIDED FOR REFERENCE PURPOSES ONLY. IBM RESERVES THE RIGHTS TO MAKE CHANGES TO THIS EVOLVING PORTFOLIO.
Discover what comes next for IBM Watson and the industries particularly suited for Watson solutions, such as healthcare, banking, and the financial sector. All of which deal with massive amounts of unstructured data coming from various sources. Find out how the advanced analytics used in Watson are being put to work in businesses around the world.
IBM Watson Analytics sets powerful analytics capabilities free so practically anyone can use them. Automated data preparation, predictive analytics, reporting, dashboards, visualization and collaboration capabilities, enable you to take control of your own analysis. You can then take the appropriate action to address a problem or seize an opportunity, all without asking IT or a data expert for help.
Ayogo ibm watson lunch and learn july 2015Mavis Dixon
Watson combines individual, social, clinical, public-domain and licensed data sources on a cloud data sharing hub, and uses cognitive analytic technology to provide relevant information to drive new insights.
Users can ask Watson for help using natural language questions. Watson then formulates and validates hypotheses based on past behaviours and available information.
IBM is investing $1B in Watson and $100M in cognitive app development to improve health engagement. Watson is being marketed as part of IBM’s BlueMix (IBM Cloud) Platform as a Service
Smarter Care - transforming the healthcare sector with IT (Danish Language)Anders Quitzau
I IBM arbejder vi tæt sammen med sundhedsvæsenet i en lang række lande og oplever derfor, at værktøjer til avanceret analyse, koordinering og samarbejde i fremtiden vil få stor betydning. Med denne avis vil vi vise, hvordan det kan lade sig gøre. Vi har samlet en række eksempler, hvor IT understøtter den positive udvikling og løfter de udfordringer, vores samfund står over for på sundhedsområ- det. Vi kalder det Smarter Care. Fremtiden rummer store muligheder, når vi tænker i Smarter Care. Med de rette værktøjer og løsninger kan vi også gribe dem.
IBM World of Watson: Applying IBM Predictive Analytics to IBM Case ManagerPyramid Solutions, Inc.
By combining IBM Predictive Analytics and Bluemix tools, you can tell which tasks, data and documents will lead a case to a more successful completion. These tools can extend both on-premise and cloud solutions that you may already have. We use predictive analytics to make a standard case solution smarter. This means knowledge workers can make decisions guided by cognitive components. With each case processed, the tool becomes more knowledgeable and accurate, taking case solutions to the next level.
Brief History of IBM Watson
Data and some figures
Watson and transformational technologies
How Watson have improve to became smarter, faster and more scalable
Presentatie Nicky Hekster eHealth Week 2017 20 januari 2017ICT Café Den Haag
Masterclass gegeven door Nicky Hekster, IBM Watson Health Technical Leader bij IBM én ambassadeur en adept van IBM Watson. Hij gaat in op de impact van zelflerende computersystemen op zaken als zorg en werk. In een wereld vol data, waar alles en iedereen gekoppeld is aan het Internet of Things, maakt cognitive computing het verschil. Zelflerende systemen doorgronden immense datastromen in milliseconden. En niet alleen feiten en cijfers, maar ook beelden, geluid, menselijke sentimenten en relaties. Ze redeneren zelf, leren continu en ondersteunen het nemen van complexe beslissingen. Ze brengen de toekomst naar het hier en nu
Using real-world evidence to investigate clinical research questionsKarin Verspoor
Adoption of electronic health records to document extensive clinical information brings with it the opportunity to utilise that information to support clinical research, and ultimately to support clinical decision making. In this talk, I discuss both these opportunities and the challenges that we face when working with real-world clinical data, and introduce some of the strategies that we are adopting to make this data more usable, and to extract more value from it. I specifically discuss the use of natural language processing to transform clinical documentation into structured data for this purpose.
Leveraging Text Classification Strategies for Clinical and Public Health Appl...Karin Verspoor
Human-generated text is a critical component of recorded clinical data, yet remains an under-utilised resource in clinical informatics applications due to minimal standards for sharing of unstructured data as well as concerns about patient privacy. Where we can access and analyse clinical text, we find that it provides a hugely valuable resource. In this talk, I will describe two projects where we have used text classification as the basis for addressing a clinical objective: (1) a syndromic surveillance project where the task is the monitoring of health and social media data sources for changes that indicate the onset of disease outbreaks, and (2) the analysis of hospital records to enable retrieval of specific disease cases, for monitoring of the hospital case mix as well as for construction of patient cohorts for clinical research studies. I will end by briefly discussing the huge potential for clinical text analysis to support changing the way modern medicine is practised.
The Learning Health System: Thinking and Acting Across ScalesPhilip Payne
A Learning Health System (LHS) can be defined as an environment in which knowledge generation processes are embedded into daily clinical practice in order to continually improve the quality, safety, and outcomes of healthcare delivery. While still largely an aspirational goal, the promise of the LHS is a future in which every patient encounter is an opportunity to learn and improve that patient’s care, as well as the care their family and broader community receives. The foundation for building such an LHS can and should be the Electronic Health Record (EHR), which provides the basis for the comprehensive instrumentation and measurement of clinical phenotypes, as well as a means of delivering new evidence at the patient- and population levels. In this presentation, we will explore the ways in which such EHR-derived phenotypes can be combined with complementary data across a spectrum from biomolecules to population level trends, to both generate insights and deliver such knowledge in the right time, place, and format, ultimately improving clinical outcomes and value.
Data sharing drivers in precision oncology, biomedical research, and healthcare. Accelerating discovery, innovation, providing credit for all stakeholders - patients, researchers, care providers, payers.
Access to treatment, care and clinical trials by patients with rare cancers...patvocates
"Access to treatment, care and clinical trials by patients with rare cancers", presented by Jan Geissler (Twitter @jangeissler) at ESMO congress in Vienna, 30 Sept 2012
How to communicate scientific and medical information to patients, advocates ...jangeissler
How to communicate scientific and medical information to patients, advocates and caregivers, presented by Jan Geissler at the European Medical Writer's Symposium (EMWA) on 12 May 2016
Guest Lecturer at the University of Dayton - 03 April 2013
Agenda:
- What is IBM Watson and why is it important?
- How is IBM putting Watson to work?
- What can we expect in the future?
How evidence affects clinical practice in egyptWafaa Benjamin
Evidence based medicine is the gold standard for clinical care.
It implies the integration of best research evidence with clinical expertise and patient values.
There is still a wide gap between availability of evidence and its incorporation into routine practice in our country.
Barriers to implementation could be personal, social, institutional, financial and legal barriers.
True practice of evidence based care can only occur where evidence based decisions coincide with patients’ beliefs and clinicians’ preferences.
Continuing medical education programs should be set with integrating evidence based medicine teaching and learning within clinical training.
The importance of presence of local national guidelines which need to take into account variation in expertise, resources and patient preferences across our geographical and cultural contexts .
Customisation of a guideline to meet the local needs of a target patient population is critical to successful implementation.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Watson – from Jeopardy to healthcare
1. IBM Watson - From Jeopardy to Healthcare
Annette Hicks
Healthcare & Social Services Industry Leader
A/NZ IBM
2. Taking on Jeopardy! – Real Language is Real Hard
• Jeopardy! poses a grand challenge for a
computing system:
– Broad range of subject matter
– Speed of accurate responses and confidence
– Requires analysing subtle meaning, irony, riddles,
and other complexities – tasks that humans excel
at but which computers traditionally do not
– Ability to understand human language
• Chess
– A finite, mathematically well-defined search space
– Large but limited number of moves and states
– Everything explicit, unambiguous mathematical
rules
The Grand Challenge
4. Cognitive systems expand the problems we can
address
4
Programmatic Systems Cognitive Systems
• Leverage traditional data sources
• Follow pre-defined rules (programs)
• Provide the same output to all users
• Are taught, not programmed.
• Learn and improve based on experience
• Interpret sensory and non-traditional
data
• Relate to each of us as individuals
• Allow us to expand and scale our own
thinking
5. Brief History of IBM Watson
R&D
Demonstration
Commercialization
Cross-industry
Applications
IBM
Research
Project
(2006 – )
Jeopardy!
Grand
Challenge
(Feb 2011)
Watson
for
Healthcare
(Aug 2011 –)
Watson
Industry
Solutions
(2012 – )
Watson
for Financial
Services
(Mar 2012 – )
Expansion
10. 75%
of
Total
$ Trillion
Why Oncology?
3X
rate cancer cost climbs
vs. std. health costs or
15-18% / yr.
$263.8B
overall costs of
cancer
in the US in 2010
20-44%
of cancer cases
receive the wrong
diagnosis initially
12. Medical
Terminology
Watson first
needed to learn
basic medical
terminology
Health and
Wellness
Watson will
broaden its base
of medical
knowledge and
deepen its
understanding of
data relevant to
patient health
Literature,
Guidelines and
Policies
Watson is taught
how to adjudicate
medical requests
subject to policies
and guidelines
supported by
literature
Clinical Treatment
Options
Watson begins to
learn how to
understand a
patient case and
identify candidate
treatment options
and relevant
supporting
evidence
Training Watson for Healthcare
14. And Creating a Corpus of Knowledge for Cancer Care
Ingestion of NCCN guidelines for breast cancer and lung cancer:
– Roughly 500,000 unique combinations of breast cancer patient attributes.
– Roughly 50,000 unique combinations of lung cancer patient attributes.
Over 600,000 pieces of evidence ingested, from 42 different publications/publishers,
including:
– The Breast Journal, National Comprehensive Cancer Network (Clinical
Practice Guidelines, Drug and Biologics compendium, et al.), American
Journal Of Hematology, Annals Of Neurology, CA: A Cancer Journal For
Clinicians, Cancer Journal, Cochrane, EBSCO, Hematological Oncology,
Hepatology, International Journal Of Cancer, Journal Of Gene Medicine,
Journal of Clinical Oncology, Journal of Oncology Practice, Massachusetts
Medical Society Journal Watch, Massachusetts Medical Society New
England Journal Of Medicine, Merck, Nephrology, UptoDate, Clinical Lung
Cancer, Current Problems in Cancer, Cancer Treatment Reviews, Elsevier's
Monographs in Cancer (multiple), Clinical Breast Cancer, European Journal
of Cancer, Lung Cancer (the journal).
IBM Confidential
19. A new era of cognitive systems has
just begun for Healthcare
Transforming how healthcare professionals
think, act, and operate
Learning through interactions
Delivering evidence based care driving better
outcomes